Nasopharyngeal carcinoma (NPC) is a highly aggressive malignancy, with most patients presenting at locally advanced stages. While immune checkpoint inhibitors, such as PD-1 blockade, have reshaped ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback